Enovis Corp

Healthcare · Medical Devices

18.50$ +1.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Enovis Corp (ENOV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 3,835 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ENOV
Line item	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	708	701	797	897	913	1,003	1,022	1,089	6,130	6,583	7,245	6,733	6,385	6,722	6,604	7,387	7,352	8,516	4,273	4,509	4,719	3,835
Current Assets	–	140	175	287	295	290	321	351	2,131	2,138	2,099	1,760	1,786	2,070	1,958	1,404	1,362	2,303	795	897	1,146	1,207
Cash	–	7.8	7.6	48	29	50	61	75	482	311	305	197	222	262	245	110	101	680	24	36	48	36
Cash & Short-Term Investments	–	7.8	7.6	48	29	50	61	75	482	311	305	197	222	412	245	110	101	680	24	36	48	36
Receivables	–	59	71	85	137	117	144	151	873	1,031	1,029	888	839	970	387	562	517	255	267	291	407	443
Inventory	–	41	57	68	80	71	58	56	494	446	443	420	404	430	497	572	565	356	427	469	547	584
Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	–	–	–	–	327	665	661	706	237	–	–	–
Goodwill	–	150	154	169	166	167	172	205	2,074	2,385	2,873	2,818	2,563	2,539	2,577	3,203	3,315	1,934	1,984	2,061	1,693	718
Intangible Assets	–	–	–	–	14	12	28	41	779	833	1,044	996	899	1,017	1,013	1,719	1,663	1,154	1,111	1,127	1,317	1,237
Total Liabilities	610	708	791	843	746	804	806	899	3,973	3,842	3,893	3,476	3,292	2,994	3,127	3,897	3,764	3,854	823	1,089	2,154	2,343
Current Liabilities	–	108	130	148	154	144	192	240	1,175	1,375	1,286	1,116	1,107	1,097	1,199	857	812	1,024	565	370	529	598
Short-Term Debt	–	1.9	2.5	2.6	5.4	9.0	10	10	35	29	9.9	5.8	5.4	5.8	5.0	68	67	30	244	22	42	60
Accounts Payable	–	28	38	49	52	37	51	54	700	860	780	569	516	587	291	360	330	155	136	132	179	188
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	1,192	2,284	2,204	2,079	40	466	1,309	1,262
Shareholders' Equity	98	-7.6	5.9	53	167	199	216	189	1,912	2,514	3,147	3,070	2,897	3,500	3,270	3,441	3,543	4,617	3,448	3,418	2,562	1,490
Retained Earnings	–	-142	-142	-109	-113	-92	-60	-56	-139	19	390	557	685	846	992	480	517	589	576	542	-283	-1,467
Shares Outstanding	7.3	7.3	7.3	7.3	11	14	15	15	30	34	41	42	41	41	40	46	46	51	54	54	55	57

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings